Related Experiment Video
Updated: Apr 11, 2026

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
Published on: May 16, 2013
Egyptian Pediatric Guidelines for the Management of Children with Isolated Thrombocytopenia Using the Adapted ADAPTE
Galila Mokhtar1, Ashraf Abdelbaky2, Amira Adly1
1Pediatric Hematology and Oncology Unit, Pediatric Department, Ain Shams University, Cairo 11566, Egypt.
Insights
This study adapts clinical practice guidelines for pediatric thrombocytopenia management in Egypt. It provides consensus recommendations for diagnosing and managing isolated thrombocytopenia in children, emphasizing clinical assessment and blood smear analysis.
Area of Science:
- Pediatric Hematology
- Clinical Practice Guidelines Adaptation
- Evidence-Based Medicine
Background:
- Thrombocytopenia is common in children, with diverse causes and outcomes.
- Accurate diagnosis and management of pediatric thrombocytopenia can be challenging.
- This study adapts international guidelines for Egypt's healthcare setting.
Purpose of the Study:
- To adapt high-quality clinical practice guidelines (CPGs) for pediatric thrombocytopenia management.
- To provide consensus recommendations tailored to the Egyptian healthcare context.
- To offer implementation tools for managing isolated thrombocytopenia in children and adolescents.
Main Methods:
- Utilized the Adapted ADAPTE methodology to identify relevant CPGs (2010-2020).
- An expert panel screened, assessed, and reviewed identified CPGs.
- Formulated adapted consensus recommendations based on the best available evidence.
Main Results:
- Developed a CPG document with consensus recommendations for pediatric thrombocytopenia management in Egypt.
- Highlighted a scarcity of evidence for specific management protocols.
- Emphasized initial clinical assessment, full blood count, and peripheral blood smear analysis.
Conclusions:
- The adapted guideline provides a framework for managing isolated thrombocytopenia in Egyptian children and adolescents.
- Initial diagnostic steps include bleeding disorder confirmation, exclusion of secondary causes, and appropriate workup.
- The International Society of Hemostasis and Thrombosis-Bleeding Assessment Tool (ISTH-SCC BAT) can aid in screening bleeding manifestations.
- Diagnosis of immune thrombocytopenic purpura (ITP) relies on excluding other causes.
- Future research should evaluate the guideline's outcomes and cost-effectiveness.
Background:
Thrombocytopenia is a prevalent presentation in childhood with a broad spectrum of etiologies, associated findings, and clinical outcomes. Establishing the cause of thrombocytopenia and its proper management have obvious clinical repercussions but may be challenging. This article provides an adaptation of the high-quality Clinical Practice Guidelines (CPGs) of pediatric thrombocytopenia management to suit Egypt's health care context.
Methods:
The Adapted ADAPTE methodology was used to identify the high-quality CPGs published between 2010 and 2020. An expert panel screened, assessed and reviewed the CPGs and formulated the adapted consensus recommendations based on the best available evidence.
Discussion:
The final CPG document provides consensus recommendations and implementation tools on the management of isolated thrombocytopenia in children and adolescents in Egypt. There is a scarcity of evidence to support recommendations for various management protocols. In general, complete clinical assessment, full blood count, and expert analysis of the peripheral blood smear are indicated at initial diagnosis to confirm a bleeding disorder, exclude secondary causes of thrombocytopenia and choose the type of work up required. The International Society of Hemostasis and thrombosis-Bleeding assessment tool (ISTH-SCC BAT) could be used for initial screening of bleeding manifestations. The diagnosis of immune thrombocytopenic purpura (ITP) is based principally on the exclusion of other causes of isolated thrombocytopenia. Future research should report the outcome of this adapted guideline and include cost-analysis evaluations.
More Related Videos
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Pharmacokinetics in Pediatric Patients: Drug Excretion
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

